Concepedia

Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register

M.H. Otten, Femke H. M. Prince, Janneke Anink, R. ten Cate, Esther P A H Hoppenreijs, Wineke Armbrust, Y. Koopman-Keemink, Philomine A van Pelt, Sylvia Kamphuis, Simone Gorter,

Annals of the Rheumatic Diseases · 2012 · 59 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Preliminary definition of improvement in juvenile arthritis

Edward H. Giannini, Nicolino Ruperto, Angelo Ravelli et al. · Arthritis & Rheumatism · 1997 · 1.1K citations

, , +5

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori et al. · The Lancet · 2008 · 797 citations

, , +8

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

Bernie Scallon, Ann Cai, Nancy Solowski et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 669 citations

, , +17

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

Carol A. Wallace, Nicolino Ruperto, Edward H. Giannini · PubMed · 2004 · 632 citations

, , +16

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz et al. · Annals of the Rheumatic Diseases · 2010 · 549 citations · Full text

, , +10